See every side of every news story
Published loading...Updated

COVID-19 Boosters Reduce Hospitalization Risk for Cancer Patients

UNITED STATES, JUL 17 – A US study shows COVID-19 boosters reduce hospitalizations by about 30% in cancer patients, but only 38% received the updated bivalent vaccine, highlighting low uptake.

  • A retrospective cohort study published July 17, 2025 in JAMA Oncology found COVID-19 boosters significantly reduced hospitalizations among cancer patients, improving outcomes for this vulnerable group.
  • Due to chemotherapy and immunotherapy, cancer patients experience weakened immunity, increasing their vulnerability to severe COVID-19 outcomes, which prompts research into vaccine effectiveness.
  • Investigators analyzed data on more than 161,000 cancer patients, finding COVID-19 boosters reduced hospitalizations and ICU admissions by 29%, preventing one event per 150–166 patients.
  • Investigators found just 38% uptake of the updated COVID-19 vaccine, and they said interventions are justified to increase booster coverage.
  • To enhance protection, cancer centers and oncology practices should implement targeted vaccination efforts, the study suggests.
Insights by Ground AI
Does this summary seem wrong?

12 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 80% of the sources are Center
80% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, July 17, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.